| Epigenetic regulator BMI1 promotes alveolar rhabdomyosarcoma proliferation and constitutes a novel therapeutic target CE Shields, S Potlapalli, SM Cuya‐Smith, SK Chappell, D Chen, ... Molecular oncology, 2021 | 12 | 2021 |
| Outbreak of central-line–associated bloodstream infections (CLABSIs) amid the coronavirus disease 2019 (COVID-19) pandemic associated with changes in central-line dressing care … SA Patel, AK Rajan, A Azeem, IL Newquist, LL Royal, KS Hemrick, ... Infection Control & Hospital Epidemiology 43 (12), 1961-1963, 2022 | 6 | 2022 |
| Discharge disposition and clinical outcomes of patients hospitalized with COVID-19 S Patel, GT Truong, A Rajan, Z Creech, R Walters, I Ng, C Destache, ... International journal of infectious diseases 130, 1-5, 2023 | 5 | 2023 |
| Outbreak of Central-Line-Associated Bloodstream Infections amid the COVID-19 Pandemic Associated with Changes in Central Line Dressing Care Accompanying Changes in Nursing … SA Patel, AK Rajan, A Azeem, IL Newquist, LL Royal, KS Hemrick, ... Infection Control and Hospital Epidemiology, 1-7, 2022 | 1 | 2022 |
| 774. Outbreak of Central-Line-Associated Bloodstream Infections (CLABSI) amid the COVID-19 Pandemic Associated with Changes in Central Line Dressing Care Accompanying Changes … A Azeem, IL Newquist, LL Royal, KS Hemrick, ZA Creech, SA Patel, ... Open Forum Infectious Diseases 8 (Supplement_1), S484-S484, 2021 | 1 | 2021 |
| INITIAL SYMPTOMS AND DEVELOPMENT OF COGNITIVE OR SLEEP DEFICITS AFTER COVID-19 HOSPITALIZATION S Patel, J Andrews Critical Care Medicine, 101-101, 2022 | | 2022 |
| Abstract A47: BMI1 constitutes a novel therapeutic vulnerability in fusion-positive rhabdomyosarcoma CE Shields, SM Cuya, S Chappell, K Rathi, S Patel, S Potlapalli, ... Cancer Research 80 (14 Supplement), A47-A47, 2020 | | 2020 |
| BMI1 constitutes a novel therapeutic vulnerability in fusion-positive rhabdomyosarcoma CE Shields, SM Cuya, S Chappell, K Rathi, S Patel, S Potlapalli, ... CANCER RESEARCH 80 (14), 67-68, 2020 | | 2020 |
| BMI1 IS A THERAPEUTIC TARGET IN RHABDOMYOSARCOMA C Shields, S Cuya, S Potlapalli, S Chappell, J Chen, K Rathi, S Patel, ... PEDIATRIC BLOOD & CANCER 67, S124-S124, 2020 | | 2020 |
| Epigenetic regulator BMI1 promotes fusion-positive rhabdomyosarcoma proliferation and constitutes a novel therapeutic target CE Shields, S Potlapalli, SM Cuya-Smith, SK Chappell, D Chen, ... bioRxiv, 2020 | | 2020 |
| Targeting epigenetic regulator BMI-1 in alveolar rhabdomyosarcoma CE Shields, SM Cuya, SK Chappell, K Rathi, S Patel, S Potlapalli, ... Cancer Research 79 (13 Supplement), 3838-3838, 2019 | | 2019 |
Gia Thinh D. TruongUniversity of Maryland Medical Center在 creighton.edu 的电子邮件经过验证
Gia Thinh D. TruongUniversity of Maryland Medical Center在 creighton.edu 的电子邮件经过验证
Zachary A CreechCreighton University School of Medicine在 creighton.edu 的电子邮件经过验证